Miles Capital Inc. Has $579,000 Stake in UnitedHealth Group Inc (UNH)

Miles Capital Inc. cut its position in UnitedHealth Group Inc (NYSE:UNH) by 25.5% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 3,616 shares of the healthcare conglomerate’s stock after selling 1,236 shares during the period. Miles Capital Inc.’s holdings in UnitedHealth Group were worth $579,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the stock. Highland Capital Management LP purchased a new stake in UnitedHealth Group during the fourth quarter worth approximately $4,001,000. Fiera Capital Corp boosted its stake in UnitedHealth Group by 10.1% in the fourth quarter. Fiera Capital Corp now owns 630,755 shares of the healthcare conglomerate’s stock worth $100,945,000 after buying an additional 58,073 shares during the last quarter. BlackRock Fund Advisors boosted its stake in UnitedHealth Group by 1.7% in the third quarter. BlackRock Fund Advisors now owns 14,442,889 shares of the healthcare conglomerate’s stock worth $2,022,004,000 after buying an additional 245,967 shares during the last quarter. Polaris Capital Management LLC boosted its stake in UnitedHealth Group by 23.5% in the fourth quarter. Polaris Capital Management LLC now owns 209,780 shares of the healthcare conglomerate’s stock worth $33,573,000 after buying an additional 39,884 shares during the last quarter. Finally, Ellington Management Group LLC purchased a new stake in UnitedHealth Group during the fourth quarter worth approximately $528,000. Hedge funds and other institutional investors own 86.67% of the company’s stock.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

UnitedHealth Group Inc (NYSE:UNH) traded down 0.020% during trading on Friday, reaching $171.505. 1,964,570 shares of the company traded hands. The firm has a 50-day moving average price of $167.19 and a 200-day moving average price of $157.47. The company has a market capitalization of $163.13 billion, a P/E ratio of 23.656 and a beta of 0.68. UnitedHealth Group Inc has a 52 week low of $128.53 and a 52 week high of $172.62.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 18th. The healthcare conglomerate reported $2.37 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.17 by $0.20. UnitedHealth Group had a return on equity of 21.20% and a net margin of 3.92%. The business earned $48.72 billion during the quarter, compared to analysts’ expectations of $48.21 billion. During the same quarter in the previous year, the business earned $1.81 EPS. The company’s revenue for the quarter was up 9.4% on a year-over-year basis. Analysts forecast that UnitedHealth Group Inc will post $9.51 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “Miles Capital Inc. Has $579,000 Stake in UnitedHealth Group Inc (UNH)” was published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are viewing this piece of content on another domain, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The original version of this piece of content can be accessed at https://www.chaffeybreeze.com/2017/04/21/unitedhealth-group-inc-unh-position-decreased-by-miles-capital-inc-updated.html.

UNH has been the topic of a number of research analyst reports. Argus restated a “buy” rating and set a $170.00 price objective on shares of UnitedHealth Group in a research report on Monday, January 23rd. Jefferies Group LLC restated a “buy” rating and set a $186.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, January 10th. Barclays PLC restated a “buy” rating and set a $187.00 price objective on shares of UnitedHealth Group in a research report on Monday, January 9th. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $177.00 price objective on the stock in a research report on Wednesday, February 22nd. Finally, Vetr downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a research report on Friday, February 10th. One analyst has rated the stock with a hold rating and twenty-three have issued a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $181.05.

In other news, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction dated Tuesday, February 14th. The stock was sold at an average price of $162.68, for a total transaction of $813,400.00. Following the completion of the sale, the director now owns 75,391 shares in the company, valued at approximately $12,264,607.88. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Richard T. Burke sold 10,000 shares of the company’s stock in a transaction that occurred on Tuesday, January 31st. The stock was sold at an average price of $161.68, for a total value of $1,616,800.00. Following the completion of the transaction, the director now owns 1,921,191 shares of the company’s stock, valued at approximately $310,618,160.88. The disclosure for this sale can be found here. Insiders have sold a total of 35,310 shares of company stock valued at $5,855,416 in the last quarter. Company insiders own 1.65% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

5 Day Chart for NYSE:UNH

Receive News & Ratings for UnitedHealth Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply